Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

397.70
Delayed Data
As of May 24
 +5.06 / +1.29%
Today’s Change
348.96
Today|||52-Week Range
605.93
-26.74%
Year-to-Date
Frank Sands Sells Visa, Baidu, Alibaba
May 24 / GuruFocus News - Paid Partner Content
Regeneron May Cure the Market Blues
May 18 / TheStreet.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Ophthotech
May 17 / MotleyFool.com - Paid Partner Content
How I Made a Huge Profit on Regeneron -- And It was One of My Biggest Mistakes Ever
May 24 / TheStreet.com - Paid Partner Content
3 Stocks You Can Buy and Hold Forever
May 16 / MotleyFool.com - Paid Partner Content
Baron Funds Comments on Regeneron Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content
Biotech groups sink their teeth into the Big Apple
May 16 / FT.com - Paid Partner Content
History Says Now Is The Time To Buy This Biotech Firm
May 18 / StreetAuthority - Paid Partner Content
5 Growth Stocks to Buy in May
May 14 / MotleyFool.com - Paid Partner Content
Regeneron Pharmaceuticals (REGN) Stock is the 'Chart of the Day'
May 18 / TheStreet.com - Paid Partner Content
Stock Market News for May 13, 2016
May 13 / Zacks.com - Paid Partner Content